Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Dec 20, 2010

Dey Pharma Settles Federal Pricing Case

Dec 17, 2010

Mylan Confirms First-to-File Patent Challenge Relating to Orapred ODT®

Dec 10, 2010

Mylan Receives Approval for Generic Version of Adalat® CC Tablets

Dec 07, 2010

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Abacavir Sulfate Tablets, 60 mg

Nov 24, 2010

Mylan Announces Completion of Senior Notes Offering

Nov 15, 2010

Mylan Announces the Conversion of its Preferred Stock into Common Stock

Nov 10, 2010

Mylan Announces Final Conversion Rate for Mandatory Convertible Preferred Stock

Nov 09, 2010

Mylan Announces Pricing of Senior Notes

Nov 09, 2010

Mylan Announces Proposed Senior Notes Private Placement

Oct 27, 2010

/C O R R E C T I O N -- Mylan Inc./

Pagination

First page
Previous page
…
Page 73
Page 74
Page 75
Page 76
Current page 77
Page 78
Page 79
Page 80
Page 81
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.